Systemic Inflammatory Response Index (SIRI) in Hypersensitivity Pneumonitis: Association with Clinical Course and Mortality

Ayshan Mammadova , Zeynep Yalçınkaya , Nilgun Yılmaz Demirci , Haluk Türktaş

  • Ayshan Mammadova: Lokman Hekim University
  • Zeynep Yalçınkaya: Department of Public Health, Afyonkarahisar Central Community Health Center, Afyonkarahisar, Turkey
  • Nilgun Yılmaz Demirci: Gazi University Faculty of Medicine
  • Haluk Türktaş: Private Lösente Hospital
  • Year : 2026
  • Vol : 42
  • Issue : 1
  •  Page : 34-40
Objective: Hypersensitivity pneumonitis (HP) is an interstitial lung disease that can range in its course from reversible inflammation to progressive fibrosis. Identifying
reliable biomarkers to predict disease phenotype and prognosis remains a major clinical challenge. This study aimed to evaluate the prognostic significance of the
Systemic Inflammatory Response Index (SIRI) in patients with HP and to investigate its association with clinical parameters, pulmonary function, and mortality.
Materials and Methods: A retrospective analysis was conducted on 73 patients diagnosed with HP between 2014 and 2022. Patients were classified into fibrotic and
non-fibrotic groups based on clinical, radiological, and histopathological criteria. Hematological indices including neutrophil-to-lymphocyte ratio (NLR), monocyteto-
lymphocyte ratio (MLR) and SIRI were calculated. Kaplan–Meier and Cox regression analyses assessed survival outcomes and independent predictors of mortality.
Results: SIRI levels were significantly higher in patients with fibrotic HP and those who died during follow-up. SIRI correlated positively with inflammatory markers,
and negatively with pulmonary function (Forced Vital Capacity), carbon monoxide diffusion capacity (DLCO%)) and 6-minute walk distance. ROC analysis demonstrated
high diagnostic accuracy for SIRI in differentiating fibrotic HP (AUC = 0.858) and predicting mortality (AUC = 0.932), with an optimal mortality cut-off of 1.92. Kaplan–
Meier survival curves illustrated significantly shorter survival in patients with SIRI >1.92 compared to those with SIRI ≤1.92, with a Log-Rank test confirming this
difference (mean survival time 74.6 ± 3.2 months vs. 127.7 ± 2.9 months; p < 0.001). In multivariable Cox analysis, fibrotic phenotype, reduced DLCO%, and SIRI >1.92
were independent predictors of mortality.
Conclusion: SIRI, as a quantitative indicator of systemic inflammation, may be regarded as a meaningful biomarker for predicting disease severity and mortality risk in
patients with hypersensitivity pneumonitis. While more evidence is needed before integration into routine clinical use, it holds potential as a supportive tool for risk
stratification, early detection of fibrotic progression, and long-term management strategy planning.
Cite this Article As : Mammadova A, Yalcinkaya Z, Yilmaz Demirci N, Turktas H. Systemic Inflammatory Response Index (SIRI) in Hypersensitivity Pneumonitis: Association with Clinical Course and Mortality. Selcuk Med J 2026;42(1): 34-40

Download Citation: Endnote/Zotero/Mendeley (RIS) RIS File

Download Citation: BibTeX BibTeX File

Conflict of interest : The authors declare that they have no conflict of interest.
This article is published under the CC BY-NC 4.0 license.
Selcuk Medical Journal
2026, Vol. 42 (1)
ISSN: 1017-6616
E-ISSN: 2149-8059
Received : , Accepted : , Published Online :

References

  1. 1.Barnes H, Troy L, Lee CT, et al. Hypersensitivity pneumonitis: Current concepts in pathogenesis, diagnosis, and treatment. Allergy. 2022;77(2):442-53. doi:10.1111/all.15017
  2. 2.Raghu G, Remy-Jardin M, Ryerson CJ, et al. Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2020; 202:36–69. doi:10.1164/rccm.202005-2032ST
  3. 3.Li YX, Chang JY, He MY, Wang HR, Luo DQ, Li FH, et al. Neutrophil-to-Lymphocyte Ratio (NLR) and Monocyte-to-Lymphocyte Ratio (MLR) Predict Clinical Outcome in Patients with Stage IIB Cervical Cancer. J Oncol. 2021;2939162. doi:10.1155/2021/2939162
  4. 4.Schietroma M, Romano L, Schiavi D, et al. Systemic inflammation response index (SIRI) as predictor of anastomotic leakage after total gastrectomy for gastric cancer. Surg Oncol. 2022;43:101791.doi:10.1016/j.suronc.2022.101791
  5. 5.Lin KB, Fan FH, Cai MQ, et al. Systemic immune inflammation index and system inflammation response index are potential biomarkers of atrial fibrillation among the patients presenting with ischemic stroke. Eur J Med Res. 2022;27(1):106.doi:10.1186/s40001-022-00733-9
  6. 6.Zhou Y, Zhang Y, Cui M, et al. Prognostic value of the systemic inflammation response index in patients with acute ischemic stroke. Brain Behav. 2022;12(6):e2619.doi:10.1002/brb3.2619
  7. 7.Atasever Akkas E, Erdis E, Yucel B. Prognostic value of the systemic immune-inflammation index, systemic inflammation response index, and prognostic nutritional index in head and neck cancer. Eur Arch Otorhinolaryngol. 2023;280(8):3821-30. doi:10.1007/s00405-023-07954-6
  8. 8.Yan D, Dai C, Xu R, et al. Predictive Ability of Systemic Inflammation Response Index for the Risk of Pneumonia in Patients with Acute Ischemic Stroke. Gerontology. 2023;69(2):181-88. doi:10.1159/000524759
  9. 9.Liu J, Ao W, Zhou J, et al. The correlation between PLR-NLR and prognosis in acute myocardial infarction. Am J Transl Res 2021;13(5):4892–99.
  10. 10.Xu Y, He H, Zang Y, et al. Systemic inflammation response index (SIRI) as a novel biomarker in patients with rheumatoid arthritis: a multi-center retrospective study. Clin Rheumatol. 2022;41(7):1989-2000. doi:10.1007/s10067-022-06122-1
  11. 11.Ma R, Cui L, Cai J, et al. Association between systemic immune inflammation index, systemic inflammation response index and adult psoriasis: evidence from NHANES. Front Immunol. 2024;15:1323174. doi:10.3389/fimmu.2024.1323174
  12. 12.Ren W, Zhang H, Cheng L, et al. Clinical significance of prognostic nutritional index (PNI)-monocyte-to-lymphocyte ratio (MLR)-platelet (PLT) score on postoperative outcomes in non-metastatic clear cell renal cell carcinoma. BMC Surg. 2023;23(1):117. doi:10.1186/s12893-023-02001-x
  13. 13.Diem S, Schmid S, Krapf M, et al. Lung Cancer Neutrophil-to-Lymphocyte ratio ( NLR ) and Platelet-to-Lymphocyte ratio ( PLR ) as prognostic markers in patients with non-small cell lung cancer ( NSCLC ) treated with nivolumab. Lung Cancer.2017;111:176–81. doi:10.1016/j.lungcan.2017.07.024
  14. 14.Köse N, Yıldırım T, Akın F, et al. Prognostic role of NLR , PLR , and LMR in patients with pulmonary embolism.Bosn J Basic Med Sci. 2020;20(2):248–53. doi:10.17305/bjbms.2019.4445
  15. 15.Yao C, Liu X, Tang Z. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD. Int J Chron Obstruct Pulmon Dis 2017; 12: 2285–2290. doi:10.2147/COPD.S141760
  16. 16.Li X, Wang L, Liu M, et al. Association between neutrophil-to-lymphocyte ratio and diabetic kidney disease in type 2 diabetes mellitus patients: a cross-sectional study. Front Endocrinol (Lausanne). 2024;14:1285509. doi:10.3389/fendo.2023.1285509
  17. 17.Zhao J, Guo XJ, Shi L. Inflammatory biomarkers in polymyositis/dermatomyositis patients with interstitial lung disease: a retrospective study. Curr Med Res Opin. 2024;40(1):113-22. doi:10.1080/03007995.2023.2281501
  18. 18.Nathan SD, Mehta J, Stauffer J, et al. Changes in Neutrophil-Lymphocyte or Platelet-Lymphocyte Ratios and Their Associations with Clinical Outcomes in Idiopathic Pulmonary Fibrosis. J Clin Med. 2021;10(7):1427. doi:10.3390/jcm10071427
  19. 19.Gu L, Xia Z, Qing B, et al. Systemic Inflammatory Response Index (SIRI) is associated with all-cause mortality and cardiovascular mortality in population with chronic kidney disease: evidence from NHANES (2001-2018). Front Immunol. 2024;15:1338025. doi:10.3389/fimmu.2024.1338025
  20. 20.Xu F, Jiang H, Li F, et al. Association between the systemic inflammation response index and mortality in the asthma population. Front Med (Lausanne). 2024;11:1446364. doi:10.3389/fmed.2024.1446364
  21. 21.Jia S, Chen Q, Huang W, et al. Relationship between systemic immune response index (SIRI) and COPD: a cross-sectional study based on NHANES 2007-2012. Sci Rep. 2025;15(1):7887. doi:10.1038/s41598-025-90947-8
  22. 22.Wang W, Yao W, Tang W, et al. Systemic inflammation response index is associated with increased all-cause and cardiovascular mortality in US adults with rheumatoid arthritis. Prev Med. 2024;185:108055.doi:10.1016/j.ypmed.2024.108055
  23. 23.Biyik M, Biyik Z, Asil M,et al. Systemic inflammation response index and systemic immune inflammation index are associated with clinical outcomes in patients with acute pancreatitis? J Invest Surg 2022;35:1613 20. doi:10.1080/08941939.2022.2084187
  24. 24.Zhou Y, Zhang Y, Cui M, Zhang Y, Shang X. Prognostic value of the systemic inflammation response index in patients with acute ischemic stroke. Brain Behav 2022;12:e2619. doi:10.1002/brb3.2619
  25. 25.Hasan SA, Eksteen B, Reid D, et al. Role of IL-17A and neutrophils in fibrosis in experimental hypersensitivity pneumonitis. J Allergy Clin Immunol. 2013;131(6):1663-73. doi:10.1016/j.jaci.2013.01.015